COMMUNIQUÉS West-GlobeNewswire

Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary Shares
07/06/2024
SAN FRANCISCO, June 07, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and [...]
Vera Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
07/06/2024
BRISBANE, Calif., June 07, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients [...]
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/06/2024
BRISBANE, Calif., June 07, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on June 4, 2024, the Compensation Committee of Vera’s Board of Directors granted inducement awards [...]
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/06/2024
BEDFORD, Mass., June 07, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on June 3, 2024, Anika granted: (i) [...]
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/06/2024
NAARDEN, the Netherlands and MIAMI, June 07, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral [...]
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/06/2024
CAMBRIDGE, Mass, June 07, 2024 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB) (“Seres” or the “Company”), a leading microbiome therapeutics company, today announced that on June 5, 2024, the Compensation [...]
StateHouse Sets Date to Report Fourth Quarter and Year-End 2023 Financial Results and First Quarter 2024 Financial Results
07/06/2024
SAN DIEGO and TORONTO, June 07, 2024 (GLOBE NEWSWIRE) -- StateHouse Holdings Inc . (“StateHouse” or the “Company”) (CSE: STHZ) (OTCQB: STHZF), a California-focused, vertically integrated cannabis company, today [...]
CORRECTION – Tevogen Bio Expresses Gratitude to Patients, First Responders, Elected Officials, and Members of the United States Congress for Attending Its Inaugural Post-Public Listing Social Engagement Event
07/06/2024
WARREN, N.J., June 07, 2024 (GLOBE NEWSWIRE) -- A release was issued under a similar headline on Thursday, June 6 th by Tevogen Bio Holdings Inc. (Nasdaq: TVGN). Please note that the second paragraph has been corrected [...]
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
07/06/2024
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM – June 7, 2024 – 07:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, [...]
PHAXIAM announces the availability of the preparatory documents for the Combined General Meeting of 28 June 2024
07/06/2024
Lyon (France) and Cambridge (MA, US), 7 June 2024 - 5.45pm CEST - PHAXIAM Therapeutics (Euronext: PHXM; FR0011471135), a biopharmaceutical company developing innovative treatments for severe and resistant bacterial [...]
PHAXIAM annonce les modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 28 juin 2024
07/06/2024
Lyon (France) et Cambridge (MA, US), le 7 juin 2024 – 17h45 CEST – PHAXIAM Therapeutics (Euronext : PHXM ; FR0011471135) société biopharmaceutique qui développe des traitements innovants contre les infections [...]
Octane Medical acquires B. Braun’s global orthobiologics business
07/06/2024
“From the start, our corporate mission has been to make regenerative medicine the standard of care. We continue to be true to this goal, and it’s the key reason why we pursued this opportunity.” — Octane Medical Group [...]
Five-year data for Roche’s Evrysdi show the majority of treated children with a severe form of spinal muscular atrophy (SMA) achieved or maintained the ability to sit, stand or walk
07/06/2024
After five years of treatment, 91% of children were alive — without treatment, children with Type 1 SMA would not be expected to live past two years of age 96% of Evrysdi-treated children could swallow, 80% could feed [...]
NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure
07/06/2024
CARMEL, Ind., June 07, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and [...]
Asensus Surgical Announces Signing of Definitive Merger Agreement with KARL STORZ
07/06/2024
KARL STORZ to acquire Asensus for $0.35 per share in cash Creating a leading surgical robotics division within KARL STORZ RESEARCH TRIANGLE PARK, N.C., June 07, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE [...]
Aeroflow Health Announces its Participation at America's Health Insurance Plans’ AHIP 2024 Flagship Conference in Las Vegas, Nevada
07/06/2024
Aeroflow’s Chief Medical Advisor to Lead a Discussion on Quality and Access to Care at the National Trade Association's Event in June ASHEVILLE, N.C., June 07, 2024 (GLOBE NEWSWIRE) -- Aeroflow Health , a pioneering [...]
European Bioplastics élit un nouveau Conseil d’administration avec Mariagiovanna Vetere et Franz Kraus comme coprésidents
07/06/2024
BRUXELLES, 07 juin 2024 (GLOBE NEWSWIRE) -- European Bioplastics (EUBP), l’association représentant les intérêts de l’industrie du bioplastique en Europe, a élu un nouveau Conseil d’administration lors de son Assemblée [...]
IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market
07/06/2024
Trading to commence effective on the market open June 14, 2024 WINTER SPRINGS, Fla., June 07, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed”) (NASDAQ: IRMD), a leading provider of innovative magnetic [...]
Article in Nature Scientific Reports Describes Mechanism of Action of SeaStar Medical’s Selective Cytopheretic Device in the Immunomodulation of Excessive Inflammation
07/06/2024
DENVER, June 07, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on [...]

Pages